19 C
New York
Friday, June 9, 2023

Is Diebold Nixdorf Incorporated (NYSE: DBD) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Diebold Nixdorf Incorporated (DBD) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0154, or 4.81%, to $0.3357. The Diebold Nixdorf Incorporated has recorded 138,872 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Diebold Nixdorf, Incorporated Further Extends Exchange Offer with Respect to its Outstanding 8.50% Senior Notes Due 2024.

<25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Stocks Info

This NYSE-listed company operates within the Software – Application industry segment, falling under the Technology sector. At the end of the last regular session, the stock closed at $0.32 and fluctuated between $0.3495 as its day high and $0.2994 as its day low. The current market capitalization of Diebold Nixdorf Incorporated is $26.48M. A total of 2.84 million shares were traded on the day, compared to an average of 3.75M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, DBD has seen 6 BUY and 12 SELL insider trades, representing the acquisition of 190,576 and the disposition of 128,558 shares. Over the last 12 months, there were 33 BUYs and 34 SELLs from insiders. Insiders purchased 588,828 shares during that period but sold 243,858.

In the most recent transaction, GREENFIELD GARY G bought 17,500 shares of DBD for 2.88 per share on Feb 14. After the transaction, the Director now owns 172,419 company shares. In a previous transaction on Feb 14, Marquez Octavio bought 7,000 shares at 2.92 per share. DBD shares that President and CEO owns now total 358,286.

Among the insiders who bought shares, Marquez Octavio acquired of 30,000 shares on Feb 13 at a per-share price of $2.28. This resulted in the President and CEO holding 351,286 shares of DBD after the transaction.


The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. DBD’s most recent ex-dividend date was 2/23/2018 when it declared a $0.10 quarterly dividend that was paid in cash on 3/16/2018. Previously, the company paid the dividend on 12/8/2017 with an ex-dividend date of 11/16/2017. The DBD stock dividend was $0.10 per share in cash.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for DBD in the last 3 months, the mean price target is $0.75 with high estimates of $1.00 and low estimates of $0.50. In terms of 52-week highs and lows, DBD has a high of $5.27 and a low of $0.32.

As of this writing, DBD has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.29 per share and a lower estimate of -$0.11. The company reported an EPS of $0.79 in the last quarter, which was 107.90% higher than expectations of $0.38.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DBD’s latest balance sheet shows that the firm has $423.20M in Cash & Short Term Investments as of fiscal 2021. There were $2.29B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was -$17.41, while its Total Shareholder’s Equity was -$837.00M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DBD is Buy with a score of 2.50.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles